Evidence map›Paper›PMID 30643008›Full record

ArticleBioscience reports2019

AKT/protein kinase B associates with β-actin in the nucleus of melanoma cells.

Larissa Leggieri Coa, Thiago Ferreira Abreu, Alexandre Keiji Tashima, Janaina Green, Renata Castiglioni Pascon, Marcelo Afonso Vallim, Joel Machado-Jr

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. AKT Phosphorylation of FOXK2 at Ser398 Impacts Breast Cancer Cell Growth and Viability.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Larissa Leggieri CoaDepartment of Biological Sciences, Universidade Federal de São Paulo - UNIFESP, Diadema - SP, Brazil.
Thiago Ferreira AbreuDepartment of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo - SP, Brazil.
Alexandre Keiji TashimaDepartment of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo - SP, Brazil.
Janaina GreenDepartment of Biological Sciences, Universidade Federal de São Paulo - UNIFESP, Diadema - SP, Brazil.
Renata Castiglioni PasconDepartment of Biological Sciences, Universidade Federal de São Paulo - UNIFESP, Diadema - SP, Brazil.
Marcelo Afonso VallimDepartment of Biological Sciences, Universidade Federal de São Paulo - UNIFESP, Diadema - SP, Brazil.
Joel Machado-JrDepartment of Biological Sciences, Universidade Federal de São Paulo - UNIFESP, Diadema - SP, Brazil joel.machadojr@gmail.com.ORCID 0000-0001-7907-3314
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The serine-threonine kinase AKT/PKB is a critical regulator of various essential cellular processes, and dysregulation of AKT has been implicated in many diseases, including cancer. Despite AKT action is known to function mainly in the cytoplasm, AKT has been reported to translocate to the nucleus. However, very little is known about the mechanism required for the nuclear import of AKT as well as its function in this cellular compartment. In the present study, we characterized the presence of endogenous nuclear AKT in human melanoma cells and addressed the possible role of AKT by exploring its potential association with key interaction nuclear partners. Confocal and Western blot analyses showed that both phosphorylated and non-phosphorylated forms of AKT are present in melanoma cells nuclei. Using mass spectrometry in combination with protein-crosslinking and co-immunoprecipitation, we identified a series of putative protein partners of nuclear AKT, including heterogeneous nuclear ribonucleoprotein (hnRNP), cytoskeleton proteins β-actin, γ-actin, β-actin-like 2 and vimentin. Confocal microscopy and biochemical analyses validated β-actin as a new nuclear AKT-interacting partner. Cofilin and active RNA Polymerase II, two proteins that have been described to interact and work in concert with nuclear actin in transcription regulation, were also found associated with nuclear AKT. Overall, the present study uncovered a yet unrecognized nuclear coupling of AKT and provides insights into the involvement of AKT in the interaction network of nuclear actin.

Indexed as

ActinsActive Transport, Cell NucleusCell NucleusCytoplasmGene Expression Regulation, NeoplasticHeterogeneous-Nuclear RibonucleoproteinsHumansMelanomaOncogene Protein v-aktPhosphorylationProtein BindingRNA Polymerase IISignal TransductionTranscription, GeneticActinsHeterogeneous-Nuclear RibonucleoproteinsOncogene Protein v-aktRNA Polymerase IIactincofilinmass spectrometryprotein kinase Bprotein-protein interactions

Identifiers

PMID30643008
PMCPMC6356016
OpenAlexW2914275689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.